Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial

Jan B. Vermorken; Anke M.E. Claessen; Harm Van Tinteren; Helen E. Gall; Renate Ezings; Syben Meijer; Rik J. Scheper; Chris J.L.M. Meijer; Elizabeth Bloemena; Janet H. Ransom; Michael G. Hanna; Herbert M. Pinedo

doi:10.1097/00042737-199903000-00029

Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial

Jan B. Vermorken, Anke M.E. Claessen, Harm Van Tinteren, Helen E. Gall, Renate Ezings, Syben Meijer, Rik J. Scheper, Chris J.L.M. Meijer, Elizabeth Bloemena, Janet H. Ransom, Michael G. Hanna, Herbert M. Pinedo

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	362
Number of pages	1
Journal	European Journal of Gastroenterology and Hepatology
Volume	11
Issue number	3
DOIs	https://doi.org/10.1097/00042737-199903000-00029
Publication status	Published - Mar 1999

Access to Document

10.1097/00042737-199903000-00029

Cite this

Vermorken, J. B., Claessen, A. M. E., Van Tinteren, H., Gall, H. E., Ezings, R., Meijer, S., Scheper, R. J., Meijer, C. J. L. M., Bloemena, E., Ransom, J. H., Hanna, M. G., & Pinedo, H. M. (1999). Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial. European Journal of Gastroenterology and Hepatology, 11(3), 362. https://doi.org/10.1097/00042737-199903000-00029

@article{5102625b949343b5bbe7193cdbcaa646,

title = "Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial",

author = "Vermorken, {Jan B.} and Claessen, {Anke M.E.} and {Van Tinteren}, Harm and Gall, {Helen E.} and Renate Ezings and Syben Meijer and Scheper, {Rik J.} and Meijer, {Chris J.L.M.} and Elizabeth Bloemena and Ransom, {Janet H.} and Hanna, {Michael G.} and Pinedo, {Herbert M.}",

year = "1999",

month = mar,

doi = "10.1097/00042737-199903000-00029",

language = "English",

volume = "11",

pages = "362",

journal = "European Journal of Gastroenterology and Hepatology",

issn = "0954-691X",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

Vermorken, JB, Claessen, AME, Van Tinteren, H, Gall, HE, Ezings, R, Meijer, S, Scheper, RJ, Meijer, CJLM, Bloemena, E, Ransom, JH, Hanna, MG & Pinedo, HM 1999, 'Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial', European Journal of Gastroenterology and Hepatology, vol. 11, no. 3, pp. 362. https://doi.org/10.1097/00042737-199903000-00029

TY - JOUR

T1 - Active specific immunotherapy for stage ii and iii human colon cancer

T2 - A randomised trial

AU - Vermorken, Jan B.

AU - Claessen, Anke M.E.

AU - Van Tinteren, Harm

AU - Gall, Helen E.

AU - Ezings, Renate

AU - Meijer, Syben

AU - Scheper, Rik J.

AU - Meijer, Chris J.L.M.

AU - Bloemena, Elizabeth

AU - Ransom, Janet H.

AU - Hanna, Michael G.

AU - Pinedo, Herbert M.

PY - 1999/3

Y1 - 1999/3

UR - http://www.scopus.com/inward/record.url?scp=85026136458&partnerID=8YFLogxK

U2 - 10.1097/00042737-199903000-00029

DO - 10.1097/00042737-199903000-00029

M3 - Article

AN - SCOPUS:85026136458

SN - 0954-691X

VL - 11

SP - 362

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

IS - 3

ER -

Active specific immunotherapy for stage ii and iii human colon cancer: A randomised trial

Access to Document

Other files and links

Cite this